Testosterone (total): what your result means.

Total testosterone is the primary male sex hormone, central to muscle mass, bone density, red blood cell production, mood and libido. Levels decline gradually with age, but low values in younger men usually have an identifiable, addressable cause.

Note: this biomarker is measured and interpreted for males; reference ranges are sex-specific.

Why Testosterone (total) matters

Symptomatic low testosterone is linked to reduced muscle and bone mass, fatigue, low mood and metabolic dysfunction. Interpretation requires context. Time of day, sleep, acute illness and SHBG all shift results, which is why guideline-based interpretation uses morning samples and repeat confirmation.

Associated risks when out of range: Sarcopenia (low). Insulin resistance (low), Fatigue/low libido (low).

What the clinical evidence shows

The evidence base behind how the HodieLabs Evidence-Based Clinical Library interprets Testosterone (total), from randomised trials, prospective cohorts and genetic (Mendelian randomisation) studies. Full citations in the reference list below.

• EMAS study (Wu et al. NEJM 2010): European population data defined true late-onset hypogonadism, consistent symptoms plus low testosterone, affecting ~2% of middle-aged and older men, far fewer than symptom questionnaires suggest: measurement matters.
• Testosterone Trials (Snyder et al. NEJM 2016): in symptomatic older men with confirmed low testosterone, treatment produced modest improvements in sexual function and mood. Benefits are real but concentrated in men with genuinely low levels.
• TRAVERSE trial (Lincoff et al. NEJM 2023): in ~5,200 men with hypogonadism and cardiovascular risk, testosterone therapy was non-inferior for major cardiovascular events, addressing the key historical safety concern for properly diagnosed patients.

Evidence-based reference ranges

The HodieLabs Evidence-Based Clinical Library interprets Testosterone (total) against published clinical authority standards, never arbitrary "optimal" ranges. Measured in nmol/L:

Clinical interpretation

• Testosterone has a strong circadian rhythm, must be measured before 10am for accurate results.
• SHBG binds testosterone; free testosterone (calculated) is more clinically relevant than total.
• Lifestyle factors (sleep, body fat, stress, alcohol) significantly impact testosterone. Optimise these before considering TRT.

What improves it: the evidence-based levers

• Resistance training
• Sleep optimisation
• Reduce visceral fat
• Clinical review if persistently low

Recommended testing frequency: Annual, as part of a comprehensive panel. Single markers are always interpreted in context.

How Testosterone (total) testing works at HodieLabs

Testosterone (total) is measured in every Health Blueprint at our Melbourne Preventative Health & Longevity Clinic, interpreted by a doctor against the guideline-cited ranges above and tracked over time through your HodieLabs membership.

References

1. Wu FC, et al. Identification of late-onset hypogonadism in middle-aged and elderly men (EMAS). N Engl J Med. 2010;363:123–135.
2. Snyder PJ, et al. Effects of testosterone treatment in older men (The Testosterone Trials). N Engl J Med. 2016;374:611–624.
3. Lincoff AM, et al. Cardiovascular safety of testosterone-replacement therapy (TRAVERSE). N Engl J Med. 2023;389:107–117.
4. Bhasin S, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103:1715–1744.

This page is general information from the HodieLabs Evidence-Based Clinical Library, not medical advice. Speak with your GP about what testing and care is appropriate for you.